Second gen vaccines could hold key to vanquishing virus

Second gen vaccines could hold key to vanquishing virus

The week-long lockdown comes at a time when India is in the midst of a veritable health crisis; not only are many of its ICUs being overwhelmed by an exponential surge in cases of the virus, but the problem is also being compounded by significant vaccine shortages…

Fortunately, there are over 270 novel candidates in development as part of a so-called second generation of vaccines, which could solve the logistical problems posed by the already approved alternatives.

In the Netherlands, for example, Akston Biosciences are beginning clinical trials for their new candidate, named AKS-452. Read more >>

Share this post